Inferior progression-free survival for Thai patients with diffuse large B-cell lymphoma treated under Universal Coverage Scheme: the impact of rituximab inaccessability

Inferior progression-free survival for Thai patients with diffuse large B-cell lymphoma treated under Universal Coverage Scheme: the impact of rituximab inaccessability

The impact of health insurance with inequitable rituximab coverage on the survival of patients with diffuse large B-cell lymphoma (DLBCL) has never been reported. We conducted a nationwide multicenter analysis on the outcome of 553 adult patients consecutively diagnosed with DLBCL between July 2003...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Tanin Intragumtornchai, Udomsak Bunworasate, Noppadol Siritanaratkul, Archrob Khuhapinant, Weerasak Nawarawong, Lalita Norasetthada, Arnuparp Lekhakula, Pairaya Rujirojindakul, Chittima Sirijerachai, Kanjana Chansung, Tawatchai Suwanban, Suporn Chuncharunee, Pimjai Niparuck, Somchai Wongkhantee, Wichean Mongkonsritragoon, Tontanai Numbenjapon
التنسيق: دورية
منشور في: 2018
الوصول للمادة أونلاين:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84870893023&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/48352
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

مواد مشابهة